Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life.
The research will be divided into two phases:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TPV | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To study in the clinical practice the choice of a specific salvage regimen for multiexperienced patients. | 48 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Reason of each VL failure or switching | 48 weeks |
Not provided
Inclusion Criteria:
Patients double PIs failure
Exclusion Criteria:
Not Applicable
Not provided
Not provided
Not provided
HIV patients
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Boehringer Ingelheim | Boehringer Ingelheim | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Investigational Site | Ancona | Italy | ||||
| Boehringer Ingelheim Investigational Site |
Not provided
Not provided
Not provided
Not provided
| Bari |
| Italy |
| Boehringer Ingelheim Investigational Site | Benevento | Italy |
| Boehringer Ingelheim Investigational Site | Bisceglie | Italy |
| Boehringer Ingelheim Investigational Site | Bologna | Italy |
| Boehringer Ingelheim Investigational Site | Brescia | Italy |
| Boehringer Ingelheim Investigational Site | Busto | Italy |
| Boehringer Ingelheim Investigational Site | Caserta | Italy |
| Boehringer Ingelheim Investigational Site | Catania | Italy |
| Boehringer Ingelheim Investigational Site | Cremona | Italy |
| Boehringer Ingelheim Investigational Site | Florence | Italy |
| Boehringer Ingelheim Investigational Site | Genova | Italy |
| Boehringer Ingelheim Investigational Site | Legnano | Italy |
| Boehringer Ingelheim Investigational Site | Milan | Italy |
| Boehringer Ingelheim Investigational Site | Naples | Italy |
| Boehringer Ingelheim Investigational Site | Padova | Italy |
| Boehringer Ingelheim Investigational Site | Palermo | Italy |
| Boehringer Ingelheim Investigational Site | Pavia | Italy |
| Boehringer Ingelheim Investigational Site | Roma | Italy |
| Boehringer Ingelheim Investigational Site | Sassari | Italy |
| Boehringer Ingelheim Investigational Site | Torino | Italy |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
Not provided
Not provided